The pioneer of minimally invasive thoracic surgery in China, who has developed tubeless VATS surgery and a series of complex surgeries under complete VATS, and has made important contributions to the early diagnosis, prognostication and molecular typing of lung cancer. Representative works published in NEJM, Lancet, BMJ, Nature Med, Cell, etc.

Dr. Ren obtained his MD from the HUST Tongji Medical College (Wuhan) and got his Ph.D from Tongji University School of Medicine(Shanghai). He received training in internal medicine at Tongji University and fellow training at the University of Colorado Cancer Center. He is currently a chief physician & vice director in medical oncology department of Shanghai Pulmonary Hospital, and a Professor of Medical Oncology at the Tongji University. He is a member of the IASLC Education Committee and previously severed as a member of the IASLC Career Development and Scholarship Committee. He is a committee member in several societies such as CSCO, CPAM in China. He participated in over 40 clinical Trials. His laboratory research focuses on ALK fusion and HER2 mutation in lung cancers and identifying predictive biomarkers for anti-PD-(L)1 therapy in non-small cell lung cancers. He has co-authored >120 peer-reviewed manuscripts.

Prof. Shun LU, MD, is currently head of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University.

He served as the leading PI for more than 20 multi-center Phase III oncology clinical trials and participated as the key contributor for more than 50 global and regional clinical trials as well. He has authored more than 200 peer-reviewed articles, many of which has published at JCO, Lancet Respiratory Medicine, Annuals of Oncology, Clinical Cancer Research, Chest and JTO etc.

Dr. LU currently serves as associate editor for Journal of Thoracic Oncology and Lung Cancer, editor for The Oncologist. Dr. Lu is the advisory board member for Center for Drug Evaluation at NMPA. He is also the chair of Chinese Lung Cancer Association and executive director of CSCO. Dr. LU’s other appointments includes the chair of Oncology Society of Shanghai Medical Association, Chair of Lung Cancer Sub-committee at Oncology Society of Chinese Medical Association, and vice president of the Oncology Branch of Shanghai Medical Doctor Association.